Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
Recruiting
Observational Study
Cholangiocarcinoma
Hepatocellular Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,250 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Inclusion Criteria :
* Age ≥ 18 years olds
* Medical care in Nephrology department since 2015
Cholangiocarcinoma:
\- Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease
Hepatocellular carcinoma:
* Hepatocellular carcinoma a…
Contacts